Stage IV Ovarian Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00352300Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerTreatment
NCT00814086Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerTreatment